Ubaryon

Ubaryon Pty Ltd operates within the highly regulated nuclear energy sector, focusing on the development and commercialization of a proprietary uranium enrichment technology. Incorporated in Australia in 2015, the company's genesis was the identification of a novel enrichment effect during environmental testing a year prior. This discovery led to the development of a chemical separation process for naturally occurring uranium isotopes.

The firm's core business revolves around its unique enrichment technology, which presents considerable potential for lower capital and operating expenditures compared to existing methods. A key technical advantage is the elimination of the conversion of uranium oxide (yellowcake) to gaseous uranium hexafluoride (UF6) and the subsequent deconversion back to an oxide, streamlining the nuclear fuel cycle. This process operates without requiring significant temperature or pressure, which reduces technical risk and enhances safety. The technology has demonstrated an enrichment factor 10 to 30 times higher than previous chemical enrichment methods.

Ubaryon's operations are subject to stringent oversight by Australian and international bodies, including the Australian Safeguards and Non-Proliferation Office (ASNO) and the International Atomic Energy Agency (IAEA). In 2018, the Australian government classified the technology as "Associated Technology," leading to heightened security obligations and the eventual relocation of its laboratories in May 2022 to the Australian Nuclear Science and Technology Organisation (ANSTO) facility at Lucas Heights. The company's patents are registered but not published due to the sensitive nature of the technology.

The company's primary clients are entities within the global nuclear fuel cycle production industry. Its business model is centered on licensing its patented technology to strategic partners for commercial deployment. A significant milestone was achieved in May 2025 through a strategic partnership with Urenco, a global leader in uranium enrichment, which included a A$5.0 million investment to advance the technology toward commercialization. Global Uranium and Enrichment Ltd (ASX: GUE) is the largest shareholder, holding a 21.9% stake.

Keywords: uranium enrichment, nuclear fuel cycle, chemical isotope separation, nuclear technology, yellowcake, Associated Technology, ANSTO, non-proliferation, Urenco, Global Uranium and Enrichment, low-cost enrichment, nuclear safeguards, IAEA, ASNO, uranium isotopes, energy technology, strategic minerals, nuclear power generation, Defence Strategic Goods List, advanced materials